Question 1

What is Roflumilast?

Accepted Answer

Roflumilast is a selective phosphodiesterase-4 (PDE4) inhibitor used to manage conditions characterized by chronic inflammation. By blocking the PDE4 enzyme, the medication helps decrease the production of certain inflammatory chemicals in the body's cells.

This medication works by targeting specific pathways to limit the swelling and irritation that contribute to chronic health issues. It is designed to help control the underlying inflammatory processes that cause symptoms to persist over time.

Question 2

What is Roflumilast used for?

Accepted Answer

Roflumilast is used to treat chronic obstructive pulmonary disease (to reduce risk of exacerbations).

Question 3

How does Roflumilast work?

Accepted Answer

Mechanism of Action

Roflumilast belongs to a class of medications known as phosphodiesterase-4 (PDE4) inhibitors. It works by blocking the action of an enzyme called PDE4, which is found in various cells throughout the body, including those involved in the immune system and inflammatory responses.

Reducing Inflammation

When the PDE4 enzyme is blocked, levels of a natural substance called cyclic adenosine monophosphate (cAMP) increase within the cells. Higher levels of cAMP help to:

Decrease the production of inflammatory chemicals.

Reduce the activity of immune cells that cause swelling and irritation.

How It Helps Specific Conditions

The way roflumilast helps depends on how it is administered:

For Lung Conditions: When taken orally for chronic obstructive pulmonary disease (COPD), it helps reduce inflammation in the airways. This can prevent the sudden worsening of symptoms, known as exacerbations, in people with severe COPD associated with chronic bronchitis.

For Skin Conditions: When applied topically as a cream or foam, it targets inflammation directly at the site of skin issues like plaque psoriasis or seborrheic dermatitis. This helps clear up red, scaly, or itchy patches by calming the overactive immune response in the skin.

Question 4

What are the brand names for Roflumilast?

Accepted Answer

Roflumilast is sold under the brand names Daliresp and Daxas .

Question 5

What are the active ingredients in Roflumilast?

Accepted Answer

The active ingredient in Roflumilast is roflumilast .

Question 6

What are the side effects of Roflumilast?

Accepted Answer

Common side effects of Roflumilast may include:

diarrhea

weight loss

nausea

and others

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Roflumilast?

Accepted Answer

Roflumilast belongs to the PDE4 inhibitor drug class.

Question 8

What is the dosage of Roflumilast and how do I take it?

Accepted Answer

Oral Tablet

Roflumilast tablets are taken by mouth once daily, ideally at the same time each day. The medication can be taken with or without food. Tablets should be swallowed whole and should not be crushed, chewed, or broken.

Topical Cream

The cream is applied to the affected areas of the skin once a day. After application, wash your hands thoroughly unless the hands are the area being treated. Avoid contact with the eyes, mouth, or vagina.

Missed Dose

If you miss a dose, skip the missed dose and resume your regular schedule. Do not use extra medication or double a dose to make up for a missed one.

Question 9

Is Roflumilast safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There are no adequate or well-controlled studies on the use of roflumilast in pregnant women. In animal studies, oral administration of the drug was associated with adverse effects, including reduced fetal weight and an increased risk of stillbirth at high doses. Roflumilast is not recommended for use during labor and delivery.

Breastfeeding

It is unknown whether roflumilast passes into human breast milk. Research in animals has shown that the drug and its active components are excreted in the milk of lactating rats. Because of the potential for serious side effects in a nursing infant, a decision should be made with a healthcare provider to either stop breastfeeding or stop taking the medication.

Consultation

If you are pregnant, planning to become pregnant, or are breastfeeding, talk to your healthcare provider about the potential risks and benefits of using roflumilast. They can help determine if the benefits of the medication outweigh the potential risks to the fetus or infant.

Question 10

What forms and strengths does Roflumilast come in?

Accepted Answer

Oral Tablets

Roflumilast is primarily administered as an oral tablet. It is typically available in strengths intended for once-daily dosing. In some cases, a lower strength may be used during the first few weeks of treatment to improve tolerability before increasing to the standard dose.

Topical Preparations

For the treatment of skin conditions, roflumilast is available in the following topical forms:

Cream: This form is applied to the skin to treat conditions like plaque psoriasis or atopic dermatitis.

Foam: This formulation is used for skin conditions such as seborrheic dermatitis, particularly on the scalp or other hair-bearing areas.

Question 11

What is the FDA approval status of Roflumilast?

Accepted Answer

FDA Approval Status

Roflumilast was first approved by the U.S. Food and Drug Administration (FDA) in 2011 as an oral tablet. The FDA has since approved topical formulations, including a cream and a foam, for various dermatological conditions.

Approved Indications

The FDA has approved roflumilast for several specific uses:

Chronic Obstructive Pulmonary Disease (COPD): The oral tablet is used to reduce the frequency of flare-ups (exacerbations) in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.

Plaque Psoriasis: The topical cream is approved for treating plaque psoriasis, including intertriginous psoriasis (psoriasis in skin folds), in adults and pediatric patients.

Seborrheic Dermatitis: The topical foam is approved for the treatment of seborrheic dermatitis in adults and pediatric patients.

Regulatory Safety Information

There are no boxed warnings or Risk Evaluation and Mitigation Strategy (REMS) requirements for roflumilast. However, the FDA has issued safety communications regarding potential psychiatric risks. Labeling for the oral medication includes warnings about the risk of suicidal ideation and behavior, as well as weight loss. Patients are typically monitored for changes in mood, depression, or anxiety during treatment.

Question 12

What should I know about Roflumilast and cost?

Accepted Answer

Factors Influencing Cost

The price of roflumilast can vary significantly based on several factors:

Formulation: Roflumilast is available as an oral tablet and a topical cream. These different delivery methods have different pricing structures.

Generic vs. Brand Name: Generic versions of the oral tablets are available, which are typically more affordable than the brand-name version. The topical cream may only be available as a brand-name product.

Insurance Coverage: Most insurance plans, including Medicare Part D, provide coverage for the generic oral tablets. However, the topical formulation may be placed on a higher cost tier or require prior authorization from a healthcare provider.

Ways to Reduce Out-of-Pocket Expenses

Patients may be able to lower their costs through the following methods:

Pharmacy Comparison: Prices for the same medication can vary between different retail pharmacies.

Manufacturer Programs: For brand-name products, manufacturers sometimes offer savings cards or patient assistance programs for eligible individuals.

Generic Substitution: When appropriate, using the generic oral tablet instead of the brand-name equivalent can reduce costs.

Roflumilast

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?